The molecular interaction of human anti-apoptotic proteins andin silicoADMET, drug-likeness and toxicity computation of N-cyclohexylmethacrylamide / Nevin Çankaya, Serap Yalçın Azarkan, Emine Tanış
Abstract Cancer is an uncontrolled growth of normal cells and apoptosis has an important role in cancer progression and cancer treatment. Antiapoptotic proteins are overexpressed in several tumors including breast, brain, lung cancer cells. The protein-ligand interaction has a critical role in drug designing. The present study aims to evaluate the interaction of synthesized N-cyclohexylmethacrylamide (NCMA) with proteins using in silico molecular docking and toxicity analyses. The NCMA monomer was synthesized and characterized by our team, previously. Kinetics stability, binding affinities and toxic potential of protein-NCMA complex were examined with the aid of molecular simulation. The toxicity results of this study indicate that NCMA is a sample with low toxic potential. According to the docking results, NCMA may be a drug active substance with chemical modifications and toxicity results support this situation. The drug-likeness and ADMET parameters were screened properties of NCMA.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:45 |
|---|---|
| Enthalten in: |
Drug and chemical toxicology - 45(2022), 5, Seite 1963-1970 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Çankaya, Nevin [VerfasserIn] |
|---|
| Links: |
FID Access [lizenzpflichtig] |
|---|
| Themen: |
ADMET |
|---|
| Umfang: |
1 Online-Ressource (8 p) |
|---|
| doi: |
10.1080/01480545.2021.1894711 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
KFL011121645 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | KFL011121645 | ||
| 003 | DE-627 | ||
| 005 | 20231109210017.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230609s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1080/01480545.2021.1894711 |2 doi | |
| 035 | |a (DE-627)KFL011121645 | ||
| 035 | |a (KFL)prod_LgpH_10.1080/01480545.2021.1894711 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 100 | 1 | |a Çankaya, Nevin |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The molecular interaction of human anti-apoptotic proteins andin silicoADMET, drug-likeness and toxicity computation of N-cyclohexylmethacrylamide |c Nevin Çankaya, Serap Yalçın Azarkan, Emine Tanış |
| 264 | 1 | |c 2022 | |
| 300 | |a 1 Online-Ressource (8 p) | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Abstract Cancer is an uncontrolled growth of normal cells and apoptosis has an important role in cancer progression and cancer treatment. Antiapoptotic proteins are overexpressed in several tumors including breast, brain, lung cancer cells. The protein-ligand interaction has a critical role in drug designing. The present study aims to evaluate the interaction of synthesized N-cyclohexylmethacrylamide (NCMA) with proteins using in silico molecular docking and toxicity analyses. The NCMA monomer was synthesized and characterized by our team, previously. Kinetics stability, binding affinities and toxic potential of protein-NCMA complex were examined with the aid of molecular simulation. The toxicity results of this study indicate that NCMA is a sample with low toxic potential. According to the docking results, NCMA may be a drug active substance with chemical modifications and toxicity results support this situation. The drug-likeness and ADMET parameters were screened properties of NCMA | ||
| 653 | |a Molecular docking | ||
| 653 | |a anti-apoptotic proteins | ||
| 653 | |a ADMET | ||
| 653 | |a drug-likeness | ||
| 653 | |a toxicology | ||
| 700 | 1 | |a Azarkan, Serap Yalçın |e verfasserin |4 aut | |
| 700 | 1 | |a Tanış, Emine |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Drug and chemical toxicology |d Abingdon : Taylor & Francis Group, 1977 |g 45(2022), 5, Seite 1963-1970 |h Online-Ressource |w (DE-627)KFL000006009 |w (DE-600)2028063-4 |w (DE-576)273879553 |x 1525-6014 |7 nnns |
| 773 | 1 | 8 | |g volume:45 |g year:2022 |g number:5 |g pages:1963-1970 |
| 856 | 4 | 0 | |u http://pharmazie.proxy.fid-lizenzen.de/fid/tandf-ejournals-pharmazie/doi.org/10.1080/01480545.2021.1894711 |m X:KFL |x Resolving-System |y FID Access |z lizenzpflichtig |
| 912 | |a ZDB-1-TFE | ||
| 912 | |a GBV_KFL | ||
| 912 | |a FID-PHARM | ||
| 935 | |i IMPORT_0628_prod_LgpH_05 | ||
| 951 | |a AR | ||
| 952 | |d 45 |j 2022 |e 5 |h 1963-1970 | ||